Close-monitor your Competitor's Move, Request sample copy
Growing R&D expenditure in pharma and biotech companies
Another key growth driver for cryo electron microscopy market has been rising R&D investments by pharmaceutical and biotechnology companies. Cryo electron microscopy is increasingly becoming a core technology for structural biology programs in the pharmaceutical industry. The technique helps in expediting projects involving structure determination of protein drug targets, lead candidate molecules as well as larger complexes involved in diseases. The three-dimensional structural data provided helps in computer aided drug design to optimize lead candidates at a much faster pace than was previously possible. Many leading pharmaceutical companies have made major investments to set up in-house cryo EM centers staffed with expert microscopists and supporting infrastructure.
Moreover, the improved resolution capabilities of the latest generation cryo electron microscopes coupled with innovations in cryo EM workflows have further increased their utility. For example, structural studies are now possible on smaller targets like drug fragments which were challenging earlier. This expands the scope of cryo EM applications considerably. With continued growth in biopharma R&D spending anticipated in the coming years on technological innovations, demand for cryo electron microscopes and associated services from this end-user segment is expected to rise substantially. This will remain a key growth driver for the global cryo electron microscopy market.
Joining thousands of companies around the world committed to making the Excellent Business Solutions.
View All Our Clients